Experience an intuitive concierge app that knows your calendar, your cards, and your taste—turning disconnected data into personalized recommendations Your data is the most valuable asset you own—but ...
Johnson & Johnson today announced positive topline results from the Phase 2b JASMINE (NCT04882878) study of adults living with systemic lupus erythematosus (SLE) and the initiation of a Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback